Register entry

Sanofi Winthrop Industrie

Data as of · How to read this entry

Registered sites
0
Active NDC listings
30
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

30

30 active NDC listings: 18 drug for further processing, 12 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 18, BULK INGREDIENT 12.

Dosage formNDCs
powder12
capsule, extended release5
tablet, film coated5
tablet3
injection, solution2
tablet, film coated, extended release2
tablet, extended release1
RouteNDCs
Labeller name on the listingNDCs
sanofi winthrop industrie30
Catalogue

Marketed products

30
BrandGeneric nameForm / routeNDC
-APOMORPHINE HYDROCHLORIDEpowder50396-6007BULK INGREDIENT
-APOMORPHINE HYDROCHLORIDEpowder50396-6009BULK INGREDIENT
-CHLORPROMAZINE HYDROCHLORIDEpowder50396-7515BULK INGREDIENT
-Diltiazem Hydrochloridecapsule, extended release53360-1210DRUG FOR FURTHER PROCESSING
-Diltiazem Hydrochloridecapsule, extended release53360-1211DRUG FOR FURTHER PROCESSING
-Diltiazem Hydrochloridecapsule, extended release53360-1212DRUG FOR FURTHER PROCESSING
-Diltiazem Hydrochloridecapsule, extended release53360-1213DRUG FOR FURTHER PROCESSING
-Diltiazem Hydrochloridecapsule, extended release53360-1214DRUG FOR FURTHER PROCESSING
-Dronedaronetablet, film coated53360-4142DRUG FOR FURTHER PROCESSING
-FEXOFENADINE HYDROCHLORIDEtablet, film coated, extended release53360-1106DRUG FOR FURTHER PROCESSING
-FEXOFENADINE HYDROCHLORIDEtablet, film coated, extended release53360-1109DRUG FOR FURTHER PROCESSING
-Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloridetablet, extended release53360-1111DRUG FOR FURTHER PROCESSING
-Hydroxocobalaminpowder50396-7902BULK INGREDIENT
-Hydroxocobalamin Acetatepowder50396-7900BULK INGREDIENT
-Irbesartantablet, film coated53360-1303DRUG FOR FURTHER PROCESSING
-Irbesartantablet, film coated53360-1305DRUG FOR FURTHER PROCESSING
-Irbesartantablet, film coated53360-1307DRUG FOR FURTHER PROCESSING
-NALOXONE HYDROCHLORIDEpowder50396-0200BULK INGREDIENT
-NALOXONE HYDROCHLORIDEpowder50396-0202BULK INGREDIENT
-NALOXONE HYDROCHLORIDEpowder50396-0203BULK INGREDIENT
-Nalbuphine Hydrochloridepowder50396-0201BULK INGREDIENT
-Naltrexone Hydrochloridepowder50396-6008BULK INGREDIENT
-PROMETHAZINE HYDROCHLORIDEpowder50396-7517BULK INGREDIENT
-TRIMIPRAMINE MALEATEpowder50396-7518BULK INGREDIENT
-avanafiltablet53360-1141DRUG FOR FURTHER PROCESSING
-avanafiltablet53360-1142DRUG FOR FURTHER PROCESSING
-avanafiltablet53360-1143DRUG FOR FURTHER PROCESSING
-clopidogrel bisulfatetablet, film coated53360-1171DRUG FOR FURTHER PROCESSING
-sarilumabinjection, solution51789-911DRUG FOR FURTHER PROCESSING
-sarilumabinjection, solution51789-924DRUG FOR FURTHER PROCESSING
Compare

Other companies listing diltiazem hydrochloride

Enquiry

Common questions

Is Sanofi Winthrop Industrie FDA approved?
Sanofi Winthrop Industrie holds no registered establishment of its own; 30 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Sanofi Winthrop Industrie make?
30 products are listed under Sanofi Winthrop Industrie in the openFDA NDC Directory, most often as powder; capsule, extended release; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.